TIDMCREO

RNS Number : 2396Q

Creo Medical Group PLC

16 October 2023

Creo Medical Group plc

("Creo" the "Company" or the "Group")

Change of Nominated Adviser and Joint Broker

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

Enquiries:

 
 Creo Medical Group plc                                               www.creomedical.com 
 Richard Rees (CFO)                                                   +44 (0)1291 606 005 
 
 Cavendish Capital Markets Limited                                    +44 (0)20 7397 8900 
 Stephen Keys / Camilla Hume (NOMAD) 
 Michael Johnson (Sales) 
 
 Numis Securities Limited (Joint 
  Broker)                                                             +44 (0)20 7260 1000 
 Freddie Barnfield / Duncan Monteith 
  / Euan Brown 
 
 Walbrook PR Ltd                        Tel: + 44 ( 0)20 7933 8780 or creo@walbrookpr.com 
 Paul McManus / Sam Allen                          Mob: +44 (0)7980 541 893 / +44 (0)7502 
  Phillip Marriage                                                                558 258 
                                                                      +44 (0)7867 984 082

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

APPFFLSUMEDSEFS

(END) Dow Jones Newswires

October 16, 2023 05:16 ET (09:16 GMT)

Creo Medical (LSE:CREO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Creo Medical Charts.
Creo Medical (LSE:CREO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Creo Medical Charts.